DR. BRUCE DAVID BEHOUNEK, MD
Osteopathic Medicine at Arcola Rd, Collegeville, PA

License number
Pennsylvania D0025817
Category
Osteopathic Medicine
Type
Internal Medicine
Address
Address 2
500 Arcola Rd, Collegeville, PA 19426
1405 Bridle Ct, Yardley, PA 19067
Phone
(484) 865-8842
(215) 321-0933
National Provider ID: 1427310572
LicenseFiles verified this license of Nov 7, 2017 at the National Plan and Provider Enumeration System.

Personal information

See more information about BRUCE DAVID BEHOUNEK at radaris.com
Name
Address
Phone
Bruce Behounek, age 70
1405 Bridle Ct, Yardley, PA 19067
(215) 321-0933
Bruce D. Behounek
Yardley, PA
(215) 321-0933
Bruce D Behounek, age 70
1405 Bridle Ct, Morrisville, PA 19067
(215) 321-0933
(215) 321-3933

Professional information

Bruce D Behounek Photo 1

Dr. Bruce D Behounek, Collegeville PA - MD (Doctor of Medicine)
Specialties:
Internal Medicine
Address:
500 Arcola Rd SUITE F3208, Collegeville 19426
(484) 865-8842 (Phone)
Certifications:
Internal Medicine, 1986
Awards:
Healthgrades Honor Roll
Languages:
English
Education:
Medical School
University of Maryland At Baltimore / Professional Schools
Graduated: 1979
University Of Maryland Medical Center

Bruce Behounek Photo 2

Method For Preventing Or Reducing Risk Of Onset Of Cardiovascular Events Employing An Hmg Coa Reductase Inhibitor

US Patent:
6369103, Apr 9, 2002
Filed:
Jan 18, 1994
Appl. No.:
08/182471
Inventors:
Bruce D. Behounek - Yardley PA
Mark E. McGovern - Philadelphia PA
Adeoye Y. Olukotun - Hopewell NJ
Assignee:
Bristol-Myers Squibb Company - Princeton NJ
International Classification:
A61K 31265
US Classification:
514512
Abstract:
A method is provided for preventing or reducing the risk of onset of a cardiovascular event by administering an HMG CoA reductase inhibitor such as pravastatin, to a patient which has one or more risk factors for a coronary and/or cerebrovascular event such as hypercholesterolemia.

Bruce Behounek Photo 3

Method For Preventing Reducing Or Risk Of Onset Of Cerebrovascular Events Employing An Hmg Coa Reductase Inhibitor

US Patent:
5674893, Oct 7, 1997
Filed:
Jun 26, 1996
Appl. No.:
8/670919
Inventors:
Bruce D. Behounek - Yardley PA
Mark E. McGovern - Philadelphia PA
Adeoye Y. Olukotun - Hopewell NJ
Assignee:
Bristol-Myers Squibb Company - Princeton NJ
International Classification:
A61K 3135
US Classification:
514451
Abstract:
A method is provided for preventing or reducing the risk of onset of a cardiovascular event by administering an HMG CoA reductase inhibitor such as pravastatin, to a patient which has one or more risk factors for a coronary and/or cerebrovascular event such as hypercholesterolemia.

Bruce Behounek Photo 4

Method For Preventing Or Reducing Risk Of Onset Of Cardiovascular Events Employing An Hmg Coa Reductase Inhibitor

US Patent:
5691375, Nov 25, 1997
Filed:
May 23, 1995
Appl. No.:
8/448211
Inventors:
Bruce D. Behounek - Yardley PA
Mark E. McGovern - Philadelphia PA
Adeoye Y. Olukotun - Hopewell NJ
Assignee:
Bristol-Myers Squibb Company - Princeton NJ
International Classification:
A61K 3121
US Classification:
514510
Abstract:
A method is provided for preventing or reducing the risk of onset of a cardiovascular event by administering an HMG CoA reductase inhibitor such as pravastatin, to a patient which has one or more risk factors for a coronary and/or cerebrovascular event such as hypercholesterolemia.

Osteopathic Medicine licenses in Pennsylvania










Other Doctors licenses in Pennsylvania